SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
143.60    2.00 (1.41%)
Bid:
143.60
Ask:
144.20
Spread: 0.60 (0.418%)
Market Cap: £245.36m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

10 Jan 2019 07:00

RNS Number : 6695M
McBride PLC
10 January 2019
 

10 January 2019

 

McBride plc

 

Trading Update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, today provides a trading update for the six months ended 31 December 2018.

 

The Group's first half continuing revenues at constant currency were 10.8% higher than the prior year. Excluding the benefit of first quarter revenues from Danlind, continuing underlying revenues were 6.0% higher. Underlying Household division sales were 5.9% higher, primarily as a result of higher sales in the East and UK regions (up 23.4% and 10.5% respectively).

 

As outlined in our recent AGM trading update, the first half year has seen raw material, packaging and logistics costs higher than anticipated, particularly in the second quarter. These have been partly mitigated by improved sales volumes and lower overheads. The pricing outlook for many of our key raw materials has improved recently and in the absence of this reversing significantly, the Board expects full year earnings to be in line with expectations, with full year profit delivery weighted to the second half.

The sale of the European Personal Care Liquids business was successfully completed during the second quarter and we continue to progress plans for the closure of our UK Aerosols factory in the second half year as expected. The integration of Danlind continued with our Danish factories transitioning onto the McBride ERP system in December.

 

The Group will announce its interim results for the six months ended 31 December 2018 on 21 February.

 

Rik De Vos, Chief Executive said;

 

"The Group has made significant strategic progress in the first half of this financial year completing the sale of Personal Care Liquids, integrating Danlind onto the McBride systems and managing our revenue growth. Margins remain our key focus at present and the recent improvement in the pricing outlook for raw materials following almost two years of significant inflation will see some recovery of the cumulative cost impact to the business. I remain confident that the Group continues to be well positioned to exploit the growth and margin opportunities in the remainder of this financial year and beyond."

 

 

For further information please contact:

 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQKLFBKFFLBBV
Date   Source Headline
3rd May 201110:29 amRNSTotal Voting Rights
28th Apr 20117:00 amRNSInterim Management Statement
20th Apr 20111:03 pmRNSTransfer of Shares out of Treasury
15th Apr 20114:46 pmRNSHolding(s) in Company
6th Apr 20115:33 pmRNSTransfer of shares into Treasury
4th Apr 20115:17 pmRNSTransfer of Shares into Treasury
1st Apr 20114:32 pmRNSTransaction in Own Shares
1st Apr 20111:44 pmRNSTotal Voting Rights
31st Mar 20117:00 amRNSTransaction in Own Shares
30th Mar 20117:30 amRNSTransaction in Own Shares
25th Mar 20112:11 pmRNSHolding(s) in Company
24th Mar 20114:15 pmRNSResult of General Meeting
18th Mar 20114:24 pmRNSDirector/PDMR Shareholding
10th Mar 20115:18 pmRNSTransaction in Own Shares
28th Feb 20112:09 pmRNSTotal Voting Rights
18th Feb 20112:21 pmRNSHolding(s) in Company
11th Feb 20113:58 pmRNSDirector/PDMR Shareholding
11th Feb 20113:57 pmRNSTreasury Stock
9th Feb 20117:00 amRNSHolding(s) in Company
8th Feb 20117:00 amRNSHalf Year Report
4th Feb 20112:53 pmRNSHolding(s) in Company
1st Feb 20113:51 pmRNSHolding(s) in Company
31st Jan 20117:00 amRNSHolding(s) in Company
27th Jan 20117:00 amRNSAppointment of Non-Executive Director
6th Jan 20117:00 amRNSTrading Update
3rd Dec 201012:18 pmRNSDirector/PDMR Shareholding
30th Nov 201010:27 amRNSTotal Voting Rights
16th Nov 201010:00 amRNSTransaction in Own Shares
29th Oct 201010:56 amRNSTotal Voting Rights
27th Oct 20101:26 pmRNSTransaction in Own Shares
26th Oct 20106:15 pmRNSResult of AGM
26th Oct 20106:15 pmRNSResult of AGM
25th Oct 20107:00 amRNSInterim Management Statement
25th Oct 20107:00 amRNSInterim Management Statement
20th Oct 20103:30 pmRNSHolding(s) in Company
20th Oct 20103:30 pmRNSHolding(s) in Company
13th Oct 20104:49 pmRNSDirector/PDMR Shareholding
13th Oct 20103:37 pmRNSAnnual Information Update
1st Oct 20103:47 pmRNSCompany Secretary Change
24th Sep 20102:59 pmRNSDirector/PDMR Shareholding
24th Sep 201012:28 pmRNSTotal Voting Rights - Correction
23rd Sep 20103:02 pmRNSAnnual Financial Report
23rd Sep 20102:57 pmRNSTotal Voting Rights
16th Sep 20105:33 pmRNSDirector/PDMR Shareholding
14th Sep 201010:09 amRNSDirector Declaration
7th Sep 20102:55 pmRNSHolding(s) in Company
2nd Sep 20107:00 amRNSAcquisition
2nd Sep 20107:00 amRNSFinal Results
30th Jul 20103:47 pmRNSTotal Voting Rights
14th Jul 20102:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.